The polypill as an alternative for preventing and treating cardiovascular disease

Authors

Keywords:

cardiovascular disease, polypill, adherence

Abstract

Addressing multiple risk factors with one pill is an attractive approach to reducing cardiovascular disease (CVD). This article explores the polypill as an alternative to CVD prevention and reviews evidence from clinical trials regarding its efficacy and potential side effects.

Author Biographies

JA Ker, University of Pretoria

Emeritus Professor of Internal Medicine, Faculty of Health Sciences, University of Pretoria, South Africa

K Outhoff, University of Pretoria

Associate Professor, Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, South Africa

Downloads

Published

2024-10-17

Issue

Vol. 5 No. 3 (2024)

Section

Review